Advisers could face using approved scripts when selling protection after criticism about poor intermediary product explanations by the FSA.
The move is being initiated by the Association of British Insurers (ABI) in an attempt to head off more severe sanctions from the regulator and could be implemented before the year's end. Market research conducted by the FSA that included adviser firms, found compelling evidence of policy features not being correctly explained during oral sales of critical illness (CI). Nick Kirwan, ABI assistant director of health and protection, believes issuing scripts is necessary, having listened to the evidence produced from mystery shopping and recorded phone calls. "It is pretty difficult t...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes